Characteristics and outcomes of patients with acute liver failure admitted to Australian and New Zealand intensive care units

Stephen Warrillow, Michael Bailey, David Pilcher, Alex Kazemi, Colin McArthur, Paul Young, Rinaldo Bellomo

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Background: Knowledge about patients with acute liver failure (ALF) in Australia and New Zealand (ANZ) is lacking. Aims: To evaluate whether the pattern of ALF would be similar to previous studies and whether, despite potentially low transplantation rates, mortality would be comparable. Methods: We obtained data from the ANZ Intensive Care Society Adult Patient Database and the ANZ Liver Transplant Registry for 10 years commencing 2005 and analysed for patient outcomes. Results: During the study period, 1 022 698 adults were admitted to intensive care units across ANZ, of which 723 had ALF. The estimated annual incidence of ALF over this period was 3.4/million people and increased over time (P = 0.001). ALF patients had high illness severity (Acute Physiology And Chronic Health Evaluation III 79.8 vs 50.1 in non-ALF patients; P < 0.0001) and were more likely to be younger, female, pregnant and immunosuppressed. ALF was an independent predictor of mortality (odds ratio 1.5 (1.26–1.79); P < 0.0001). At less than 23%, the use of liver transplantation was low, but the mortality of 39% was similar to previous studies. Conclusions: ALF is a rare but increasing diagnosis in ANZ intensive care units. Low transplantation rates in ANZ for ALF do not appear to be associated with higher mortality rates than reported in the literature.

Original languageEnglish
Pages (from-to)874-885
Number of pages12
JournalInternal Medicine Journal
Volume49
Issue number7
DOIs
Publication statusPublished - Jul 2019

Keywords

  • acute liver failure
  • emergency liver transplantation
  • paracetamol overdose

Cite this

@article{99704da30cd54395beacaf84735e90e4,
title = "Characteristics and outcomes of patients with acute liver failure admitted to Australian and New Zealand intensive care units",
abstract = "Background: Knowledge about patients with acute liver failure (ALF) in Australia and New Zealand (ANZ) is lacking. Aims: To evaluate whether the pattern of ALF would be similar to previous studies and whether, despite potentially low transplantation rates, mortality would be comparable. Methods: We obtained data from the ANZ Intensive Care Society Adult Patient Database and the ANZ Liver Transplant Registry for 10 years commencing 2005 and analysed for patient outcomes. Results: During the study period, 1 022 698 adults were admitted to intensive care units across ANZ, of which 723 had ALF. The estimated annual incidence of ALF over this period was 3.4/million people and increased over time (P = 0.001). ALF patients had high illness severity (Acute Physiology And Chronic Health Evaluation III 79.8 vs 50.1 in non-ALF patients; P < 0.0001) and were more likely to be younger, female, pregnant and immunosuppressed. ALF was an independent predictor of mortality (odds ratio 1.5 (1.26–1.79); P < 0.0001). At less than 23{\%}, the use of liver transplantation was low, but the mortality of 39{\%} was similar to previous studies. Conclusions: ALF is a rare but increasing diagnosis in ANZ intensive care units. Low transplantation rates in ANZ for ALF do not appear to be associated with higher mortality rates than reported in the literature.",
keywords = "acute liver failure, emergency liver transplantation, paracetamol overdose",
author = "Stephen Warrillow and Michael Bailey and David Pilcher and Alex Kazemi and Colin McArthur and Paul Young and Rinaldo Bellomo",
year = "2019",
month = "7",
doi = "10.1111/imj.14167",
language = "English",
volume = "49",
pages = "874--885",
journal = "Internal Medicine Journal",
issn = "1444-0903",
publisher = "Wiley-Blackwell",
number = "7",

}

Characteristics and outcomes of patients with acute liver failure admitted to Australian and New Zealand intensive care units. / Warrillow, Stephen; Bailey, Michael; Pilcher, David; Kazemi, Alex; McArthur, Colin; Young, Paul; Bellomo, Rinaldo.

In: Internal Medicine Journal, Vol. 49, No. 7, 07.2019, p. 874-885.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Characteristics and outcomes of patients with acute liver failure admitted to Australian and New Zealand intensive care units

AU - Warrillow, Stephen

AU - Bailey, Michael

AU - Pilcher, David

AU - Kazemi, Alex

AU - McArthur, Colin

AU - Young, Paul

AU - Bellomo, Rinaldo

PY - 2019/7

Y1 - 2019/7

N2 - Background: Knowledge about patients with acute liver failure (ALF) in Australia and New Zealand (ANZ) is lacking. Aims: To evaluate whether the pattern of ALF would be similar to previous studies and whether, despite potentially low transplantation rates, mortality would be comparable. Methods: We obtained data from the ANZ Intensive Care Society Adult Patient Database and the ANZ Liver Transplant Registry for 10 years commencing 2005 and analysed for patient outcomes. Results: During the study period, 1 022 698 adults were admitted to intensive care units across ANZ, of which 723 had ALF. The estimated annual incidence of ALF over this period was 3.4/million people and increased over time (P = 0.001). ALF patients had high illness severity (Acute Physiology And Chronic Health Evaluation III 79.8 vs 50.1 in non-ALF patients; P < 0.0001) and were more likely to be younger, female, pregnant and immunosuppressed. ALF was an independent predictor of mortality (odds ratio 1.5 (1.26–1.79); P < 0.0001). At less than 23%, the use of liver transplantation was low, but the mortality of 39% was similar to previous studies. Conclusions: ALF is a rare but increasing diagnosis in ANZ intensive care units. Low transplantation rates in ANZ for ALF do not appear to be associated with higher mortality rates than reported in the literature.

AB - Background: Knowledge about patients with acute liver failure (ALF) in Australia and New Zealand (ANZ) is lacking. Aims: To evaluate whether the pattern of ALF would be similar to previous studies and whether, despite potentially low transplantation rates, mortality would be comparable. Methods: We obtained data from the ANZ Intensive Care Society Adult Patient Database and the ANZ Liver Transplant Registry for 10 years commencing 2005 and analysed for patient outcomes. Results: During the study period, 1 022 698 adults were admitted to intensive care units across ANZ, of which 723 had ALF. The estimated annual incidence of ALF over this period was 3.4/million people and increased over time (P = 0.001). ALF patients had high illness severity (Acute Physiology And Chronic Health Evaluation III 79.8 vs 50.1 in non-ALF patients; P < 0.0001) and were more likely to be younger, female, pregnant and immunosuppressed. ALF was an independent predictor of mortality (odds ratio 1.5 (1.26–1.79); P < 0.0001). At less than 23%, the use of liver transplantation was low, but the mortality of 39% was similar to previous studies. Conclusions: ALF is a rare but increasing diagnosis in ANZ intensive care units. Low transplantation rates in ANZ for ALF do not appear to be associated with higher mortality rates than reported in the literature.

KW - acute liver failure

KW - emergency liver transplantation

KW - paracetamol overdose

UR - http://www.scopus.com/inward/record.url?scp=85068898827&partnerID=8YFLogxK

U2 - 10.1111/imj.14167

DO - 10.1111/imj.14167

M3 - Article

VL - 49

SP - 874

EP - 885

JO - Internal Medicine Journal

JF - Internal Medicine Journal

SN - 1444-0903

IS - 7

ER -